The average daily trading volume of the Japanese stock market surpasses 10 trillion yen, doubling compared to the same period last year.
Glonghui, May 26｜According to Nikkei Chinese Edition, trading activity in the Japanese stock market is very robust. The average daily trading volume on the Tokyo Stock Exchange Prime Market has exceeded 10 trillion yen, doubling compared to the same period last year. Rising share prices have attracted an influx of overseas capital, and individual investors are also engaging in increasingly active short-term trading. The Japanese stock market is experiencing a surge in high-volume trading and price appreciation, clearly demonstrating the market's strong momentum in absorbing sell pressure and steadily moving upwards. Overseas investors have become the main force driving the massive trading volumes. Transaction data from various investment segments of the Tokyo Stock Exchange show that, in April, the Prime Market saw purchase amounts of 129 trillion yen and sales of 124 trillion yen, with total trading reaching 254 trillion yen—almost doubling compared to April 2025 (when the total trading volume was 129 trillion yen). The simultaneous increase in share prices and enormous transaction volumes suggests the uptrend has sustainability. Pension funds and investment trusts, among other Japanese institutional investors, have consistently been net sellers; under these circumstances, the trend of corporations and others selling cross-held shares is also expanding. The reason is that buying interest has been absorbing this large volume of sales, resulting in rising share prices. Due to improved liquidity, even large orders are less likely to trigger price volatility, and there is a promising prospect of forming a virtuous cycle that stabilizes the market and attracts new investors.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
University of Michigan October Consumer Sentiment Index falls to a five-month low, with the Current Economic Conditions Indicator hitting a historic low
The University of Michigan’s Consumer Sentiment Index for October dropped to 46.3, below the market expectation of 47.6. The component reflecting current economic conditions decreased to 44.7, setting a new historical low, while the expectations component edged up to 47.3, marking its first rebound since July. Consumers’ one-year inflation expectations rose to 4.7%, and five-to-ten-year inflation expectations increased to 3.5%. According to the survey director, consumers from different political parties agree that the economic outlook has weakened compared to the beginning of the year.
WTI holds steady as traders weigh US-Iran tensions and supply risks
Japan: Bond outflows reshape global yields - Commerzbank
BUZZ - JPMorgan gives “overweight” rating to LSD-based therapies, Definium stock rises
Latest Updates, October 9th - ** Definium Therapeutics (DFTX.O) shares rose 7.4% to $36.7 ** If the rally holds, the stock is set for its biggest single-day gain since June ** JPMorgan initiated coverage of the stock with an "Overweight" rating and a target price of $84 ** The bank stated that Definium’s lead candidate drug, DT120 ODT, has the potential to transform the treatment landscape for neuropsychiatric disorders ** Based on current data, the institution considers DT120 ODT (an LSD oral formulation for the treatment of major depressive disorder and generalized anxiety disorder) to be a "de-risked asset" ** The new target price implies a 145.7% upside from the latest closing price ** "While changes in the macro environment may present potential investment risks to the sector, we believe the positives for Definium outweigh the negatives," the bank stated ** A period of "frequent landmark events" is expected ahead, including plans to submit a new drug application to the FDA in the first half of 2027 ** The bank projects that total sales of DT120 orally disintegrating tablets (ODT) will approach $5 billion by 2035 ** Including intraday volatility, the stock has more than doubled in value year-to-date (For the convenience of non-English speakers, Reuters has automated this report’s translation into several other languages. Due to possible errors in automated translation or lack of full context, Reuters does not guarantee the accuracy of the automated translation and provides it solely as a convenience to readers. Reuters accepts no liability for any damage or loss arising from the use of automated translation.)
Crypto prices
More
